Atıf Formatları
Noninvasive assessment of liver disease severity in patients with nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes.
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

G. Pennisi Et Al. , "Noninvasive assessment of liver disease severity in patients with nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes.," Hepatology (Baltimore, Md.) , 2023

Pennisi, G. Et Al. 2023. Noninvasive assessment of liver disease severity in patients with nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes.. Hepatology (Baltimore, Md.) .

Pennisi, G., Enea, M., Falco, V., Aithal, G. P., Palaniyappan, N., Yilmaz, Y., ... Boursier, J.(2023). Noninvasive assessment of liver disease severity in patients with nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes.. Hepatology (Baltimore, Md.) .

Pennisi, Grazia Et Al. "Noninvasive assessment of liver disease severity in patients with nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes.," Hepatology (Baltimore, Md.) , 2023

Pennisi, Grazia Et Al. "Noninvasive assessment of liver disease severity in patients with nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes.." Hepatology (Baltimore, Md.) , 2023

Pennisi, G. Et Al. (2023) . "Noninvasive assessment of liver disease severity in patients with nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes.." Hepatology (Baltimore, Md.) .

@article{article, author={Grazia Pennisi Et Al. }, title={Noninvasive assessment of liver disease severity in patients with nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes.}, journal={Hepatology (Baltimore, Md.)}, year=2023}